Pinnacle Wealth Planning Services’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67K Sell
15
-3
-17% -$355 ﹤0.01% 2476
2025
Q4
$2.43K Buy
+18
New +$1.96K ﹤0.01% 2443

Other funds holding ABVX

Pinnacle Wealth Planning Services's ABVX Position: Q1 2026 in Review

Pinnacle Wealth Planning Services reduced its Abivax (ABVX) stake by 17% in Q1 2026, selling an estimated $355 and leaving 15 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2476.

Pinnacle Wealth Planning Services first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.43K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Pinnacle Wealth Planning Services held 15 shares of Abivax worth $1.67K as of Q1 2026.
  • Pinnacle Wealth Planning Services sold 3 Abivax shares in Q1 2026, an estimated $355.
  • Abivax made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #2476 holding.
  • Pinnacle Wealth Planning Services first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Pinnacle Wealth Planning Services's Abivax position peaked at $2.43K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.